Fundraising FoxSerif Biomedicines
Cambridge, US · 2 known investors
Find your way into Serif Biomedicines
Sign up to see every warm intro you have to Serif Biomedicines
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Serif Biomedicines team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Serif Biomedicines develops DNA-based therapies and nucleic acid delivery technologies for genetic medicine. The company aims to create tailored, long-acting treatments across multiple diseases.
Founders & leadership
JR
Jacob RubensChief Executive OfficerJacob Rubens studied synthetic biology at MIT, where he earned a PhD, and has co-founded multiple biotechnology companies including Quotient Therapeutics (where he served as CEO and President) and Tessera Therapeutics (where he held chief scientific officer and innovation officer roles). He is currently CEO of Serif Biomedicines, which develops DNA-based therapies and nucleic acid delivery technologies for genetic medicine.
Investors · 2
Flagship Pioneeringlisted by Flagship PioneeringCambridge · $500K – $10M
How we know: Flagship Pioneering's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
Frequently asked questions
- What does Serif Biomedicines do?
- Serif Biomedicines develops DNA-based therapies and nucleic acid delivery technologies for genetic medicine. The company aims to create tailored, long-acting treatments across multiple diseases.
- Who are Serif Biomedicines's investors?
- Serif Biomedicines's investors include Flagship Pioneering, Modi Ventures.
- Where is Serif Biomedicines headquartered?
- Serif Biomedicines is headquartered in Cambridge, US.